Group leader
The work, led by a team from the CSIC and IDIBELL, with the collaboration of IBEC, manages to visualise how embryonic cells eliminate bacterial infections, before the formation of the immune system. The research describes a mechanism of phagocytosis similar to that used by white blood cells, and reveals that this mechanism is also present in human embryos.
A study led by the Institute for Bioengineering of Catalonia (IBEC) and the Universitat Autònoma de Barcelona (UAB) has uncovered how co-infection by Pseudomonas aeruginosa and Mycobacterium abscessus, two common lung pathogens, can suppress immune responses and worsen outcomes in patients with respiratory diseases. The findings, published today in the journal Virulence, provide new insight into why polymicrobial infections are particularly difficult to treat and open the door to new therapeutic strategies.
IBEC researcher Eduard Torrents has been awarded the ICREA Academia distinction by the Catalan Institute for Research and Advanced Studies (ICREA). The head of IBEC’s Bacterial Infections: Antimicrobial Therapies group received the award in the Life and Health Sciences category.
Researchers from across Europe gathered for the kick-off meeting of the SPM4.0 project, an innovative Marie Curie Skłodowska Doctoral Network (MSCA-DN) dedicated to advancing the capabilities of autonomous Scanning Probe … Read more
The 1st Translational Collaboration Day between the Vall d’Hebron Institute of Research (VHIR) and the Institute of Bioengineering of Catalonia (IBEC), held on 21st November, was an opportunity to learn about the projects and research lines of both institutions and to promote interaction between professionals.
Research led by IBEC has analysed the antimicrobial activity of human histones against various bacteria, both in solution and in biofilm. The results are very promising and open the door to finding new, more effective treatments, particularly against Pseudomonas aeruginosa infections. This bacterium is mainly responsible for the development of chronic wounds and lung failure in patients with cystic fibrosis and other respiratory diseases.
IBEC will coordinate SPM4.0 and participate as a partner in ENTRY-DM, two of the projects selected in the 2023 call for PhD networks within the Marie Skłodowska-Curie Actions (MSCA). Thanks to these two projects, IBEC will add three new PhD students to its staff.
IBEC dedicates the 4th edition of its fundraising program, Faster Future, to develop novel strategies to treat infections and diseases caused by antibiotic-resistant bacteria. Specifically, the research seeks to fight … Read more
Chronic wounds are a challenge for microbiologists due to biofilms, complex structures where bacteria protect themselves from antibiotics, preventing infections from being treated effectively. A research team led by the … Read more
IBEC researchers have published a study in the journal Nature in which they have designed and developed a three-molecule complex that increases the efficacy and stability, while reducing the toxicity, … Read more